Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808872 · ClinicalTrials.gov registry record
Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP
A clinical trial, sponsored by Radiometer Medical ApS.
- Completed
- Registry status
- 569
- Enrollment target
NCT01808872: Completed study, sponsored by Radiometer Medical ApS.
NCT01808872 is a clinical trial that has completed, run by Radiometer Medical ApS. The registered enrollment target is 569 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01808872 has completed, sponsored by Radiometer Medical ApS.
- COMPLETED
- Registry status
- 569 participants
- Enrollment target
Study Summary
The AQT90 FLEX B-type Natriuretic Peptide (BNP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) Tests are in vitro diagnostic assays intended as an aid in the diagnosis and assessment of the severity of heart failure in point-of-care and laboratory settings. The purpose of the study is to establish the clinical performance of the AQT90 FLEX BNP and NT-proBNP assays for both whole blood and plasma in the intended use population.
Primary Outcome
Clinical sensitivity and specificity with 95 % confidence intervals of the AQT90 FLEX BNP and NT-proBNP assays will be determined at the clinical cut-off in heart failure patients divided by age, gender and New York Heart Association (NYHA) functional classification.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 569 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-05 |
What the finished NCT01808872 record still lists
NCT01808872 is an observational study that tracks outcomes without assigning an intervention. The registered 569 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01808872 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01808872 about?
NCT01808872 is a clinical study titled "Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP". The AQT90 FLEX B-type Natriuretic Peptide (BNP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) Tests are in vitro diagnostic assays intended as an aid in the diagnosis and assessment of the severity of heart failure in point-of-care and laboratory settings. The purpose of the study is to ...
What is the current status of trial NCT01808872?
This trial is currently completed. The enrollment target is 569 participants. The study started on 2013-03. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT01808872?
This trial is sponsored by Radiometer Medical ApS, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000645 · 570 participants · NA
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
- NCT06239844 · 570 participants · NA
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
- NCT06701903 · 570 participants · Phase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- NCT07266831 · 570 participants · Phase 2
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia